The estimated Net Worth of Ventures Iv, L.P.5 Am Co In... is at least 12.7 百万$ dollars as of 22 December 2020. Ventures In owns over 500,000 units of Homology Medicines Inc stock worth over 168,735$ and over the last 4 years Ventures sold FIXX stock worth over 12,535,000$.
Ventures has made over 2 trades of the Homology Medicines Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Ventures sold 500,000 units of FIXX stock worth 6,410,000$ on 22 December 2020.
The largest trade Ventures's ever made was selling 500,000 units of Homology Medicines Inc stock on 22 December 2020 worth over 6,410,000$. On average, Ventures trades about 500,000 units every 4 days since 2020. As of 22 December 2020 Ventures still owns at least 181,435 units of Homology Medicines Inc stock.
You can see the complete history of Ventures In stock trades at the bottom of the page.
Over the last 7 years, insiders at Homology Medicines Inc have traded over 108,214,465$ worth of Homology Medicines Inc stock and bought 3,033,333 units worth 51,999,993$ . The most active insiders traders include Steven Gillis、James Edeerfield Management...、Kush Parmar. On average, Homology Medicines Inc executives and independent directors trade stock every 26 days with the average trade being worth of 106,785$. The most recent stock trade was executed by Paul Alloway on 25 March 2024, trading 23,530 units of FIXX stock currently worth 21,883$.
homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
Homology Medicines Inc executives and other stock owners filed with the SEC include: